de Vasconcelos Sandra, Mustak Hamzah, Mabogo Maanda, Dave Joel
Department of Ophthalmology, Faculty of Surgery, University of Cape Town, Cape Town, South Africa.
Department of Ophthalmology, Faculty of Surgery, University of Pretoria, Pretoria, South Africa.
J Coll Med S Afr. 2025 Feb 28;3(1):127. doi: 10.4102/jcmsa.v3i1.127. eCollection 2025.
Thyroid-associated ophthalmopathy (TAO) is a common and debilitating manifestation of Graves' disease (GD) associated with poor clinical outcomes including impaired quality-of-life (QoL) and socio-economic status. Data on TAO in Africa is scarce and unavailable in the South African population.
This descriptive cross-sectional study focussed on GD patients attending the thyroid clinic at Groote Schuur Hospital, in Cape Town, South Africa. Participants were evaluated for TAO activity and severity according to the European Group on Graves' Orbitopathy (EUGOGO) criteria. Quality-of-life was assessed using the TED-QoL questionnaire.
Thyroid-associated ophthalmopathy prevalence was 59.8%. The majority of TAO patients had mild disease ( = 73; 59.8%). Based on the severity score alone, moderate to severe disease ( = 41; 33.6%) and sight-threatening disease ( = 8; 6.6%) were identified and referred for further ophthalmological intervention. There was a statistically significant increase in the QoL score with an increase in the severity score ( < 0.05).
The prevalence of orbitopathy was found to be higher than that reported from other continents, but our severity distribution was similar. This study emphasised the importance of evaluating severity as well as the psychosocial aspect of TAO to allow for the identification of and interdisciplinary management of patients to improve patient outcomes.
This study was the first to attempt to determine the prevalence and severity of TAO in South Africa. The importance of early TAO detection using both, a clinical and psychosocial tool, is highlighted in this study to reduce the complications associated with TAO.
甲状腺相关性眼病(TAO)是格雷夫斯病(GD)常见且使人衰弱的一种表现,会导致包括生活质量(QoL)受损和社会经济地位下降等不良临床后果。非洲关于TAO的数据稀缺,南非人群中尚无此类数据。
这项描述性横断面研究聚焦于南非开普敦格罗特舒尔医院甲状腺门诊的GD患者。根据欧洲格雷夫斯眼眶病专家组(EUGOGO)标准对参与者的TAO活动和严重程度进行评估。使用TED-QoL问卷评估生活质量。
甲状腺相关性眼病患病率为59.8%。大多数TAO患者病情较轻(n = 73;59.8%)。仅根据严重程度评分,确定了中度至重度疾病(n = 41;33.6%)和威胁视力的疾病(n = 8;6.6%),并将这些患者转诊接受进一步眼科干预。随着严重程度评分增加,生活质量评分有统计学显著升高(P < 0.05)。
发现眼眶病患病率高于其他各大洲报告的患病率,但我们的严重程度分布相似。本研究强调了评估TAO严重程度以及心理社会方面的重要性,以便识别患者并进行跨学科管理,从而改善患者预后。
本研究首次尝试确定南非TAO的患病率和严重程度。本研究强调了使用临床和心理社会工具早期检测TAO的重要性,以减少与TAO相关的并发症。